Compounded drugs marketed to TRICARE beneficiaries undergoing close examination by federal investigators
6/5/2015 2:27:52 AM
Ongoing investigations by both the Department of Defense (DOD) and a major U.S. media organization allege that suspicious marketing and prescribing activities have led to astronomical increases in TRICARE costs for compounded medications. According to the Military Times, TRICARE paid $769 million for compound prescriptions between January and March 2015, .
more.
No comments:
Post a Comment